ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates scPharmaceuticals (SCPH) delivered earnings and revenue surprises of -25.93% and 3.67%, respectively, for the quarter ended March 2025. Do the…
ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates scPharmaceuticals (SCPH) delivered earnings and revenue surprises of 12.50% and 0.81%, respectively, for the quarter ended December 2024. Do the…
ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy? ScPharmaceuticals (SCPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…